Examining the expression of EMT markers, we found that silencing FASN reversed the hyperglycaemia-induced EMT phenotype leading to increased expression of E-cadherin (p < .05) and decreased vimentin (p < .01) and fibronectin (p < .01) (Fig. 2a (i-v)). The gene discussed is FASN; the disease is Hyperglycemia.